Loteprednol (as the ester loteprednol etabonate) is a corticosteroid used in optometry and ophthalmology. Marketed by Bausch and Lomb as Lotemax in the U.S. ocular applications for this drug include the treatment of inflammation of the eye due to allergies (according to the prescription information sheet) as well as chronic forms of keratitis (e.g.: adenoviral and Thygeson’s keratitis) vernal keratoconjunctivitis pingueculitis and episcleritis.
This page contains content from the copyrighted Wikipedia article "Loteprednol"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
